Want to see VMD full AI Analyst Report?
VMD Stock Chart & Stats
$6.88
$0.08(0.94%)
At close: 4:00 PM EST
$6.88
$0.08(0.94%)
Day’s Range― - ―
52-Week Range$5.93 - $12.41
Previous CloseN/A
Volume27.16K
Average Volume (3M)293.94K
Market Cap
$465.41M
Enterprise Value$406.36M
Total Cash (Recent Filing)$9.76M
Total Debt (Recent Filing)$12.44M
Price to Earnings (P/E)31.4
Beta0.62
Next Earnings
Aug 12, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.39
Shares Outstanding38,336,803
10 Day Avg. Volume397,808
30 Day Avg. Volume293,943
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue1.42
Enterprise Value/Gross Profit2.47
Enterprise Value/Ebitda7.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.47
Revenue Forecast (FY)$317.30M
Bulls Say, Bears Say
Bulls Say
Recurring, Diversified Revenue MixThe company is shifting from ventilator concentration toward a broader revenue base (sleep PAP, HME rentals, equipment & supplies). Recurring rental and resupply streams (PAP growth and consumables) increase revenue predictability and reduce capital intensity, supporting durable cash flow and scale benefits over months.
High, Sustainable Gross And EBITDA MarginsConsistently strong gross and EBITDA margins reflect the DME rental model and resupply economics, enabling profitable scaling. Margin resilience provides a buffer against reimbursement pressures and supports reinvestment in clinical services and expansion while maintaining operating profitability over the medium term.
Conservative Balance Sheet And LiquidityVery low leverage and meaningful available credit give the company flexibility to fund growth, absorb reimbursement or working-capital variability, and execute buybacks or acquisitions. Strong liquidity and shrinking long-term debt reduce refinancing risk and support durable strategic initiatives over the next several quarters.
Bears Say
Policy-driven Ventilator Access Risk (NCD Compliance)New NCD compliance rules increase patient eligibility assessment and turnover, pressuring ventilator net census and rental revenue. This regulatory-driven access risk can persist for months, requiring operational changes and advocacy; it structurally raises utilization volatility for core ventilator services.
Volatile Free Cash Flow ConversionWhile operating cash flow generally exceeds net income, free cash flow has been uneven due to timing and reinvestment, limiting consistently available cash for debt reduction or discretionary returns. Sub‑par FCF conversion relative to earnings signals ongoing capital/reinvestment needs that may constrain flexibility.
Expanded Long‑term Incentive Pool Increases Dilution RiskA materially larger equity compensation reserve aligns management but raises potential dilution and future share‑based compensation expense. Over the medium term this can pressure EPS and shareholder returns and raise SG&A compensation line items as the company scales incentive usage to retain talent.
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was $5.93 and its highest was $12.41 in the past 12 months.
What is Viemed Healthcare US’s market cap?
Viemed Healthcare US’s market cap is $465.41M.
When is Viemed Healthcare US’s upcoming earnings report date?
Viemed Healthcare US’s upcoming earnings report date is Aug 12, 2026 which is in 33 days.
How were Viemed Healthcare US’s earnings last quarter?
Viemed Healthcare US released its earnings results on May 05, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.03.
Is Viemed Healthcare US overvalued?
According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued.
Does Viemed Healthcare US pay dividends?
Viemed Healthcare US does not currently pay dividends.
What is Viemed Healthcare US’s EPS estimate?
Viemed Healthcare US’s EPS estimate is 0.12.
How many shares outstanding does Viemed Healthcare US have?
Viemed Healthcare US has 38,336,803 shares outstanding.
What happened to Viemed Healthcare US’s price movement after its last earnings report?
Viemed Healthcare US reported an EPS of $0.06 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went down -12.216%.
Which hedge fund is a major shareholder of Viemed Healthcare US?
Currently, no hedge funds are holding shares in VMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VMD Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 7.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $347.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.2%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
72.93%
12-Months-Change
Fundamentals
Return on Equity
10.66%
Trailing 12-Months
Asset Growth
10.83%
Trailing 12-Months
Company Description
Viemed Healthcare US
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VMD Company Deck
VMD Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial progress: revenue growth of 28% YoY, substantial free cash flow improvement, meaningful scaling in sleep (PAP up 57% YoY) and maternal health expansion, improved capital efficiency and a stronger, more diversified revenue mix. Near-term headwinds are largely related to NCD-driven compliance effects in ventilation (higher turnover and temporary pressure on net census), some seasonality, and comparability issues from a prior-year gain. Management reiterated positive guidance, tightened revenue guidance upward, and highlighted continued margin and cash-flow improvement, indicating confidence in execution.View all VMD earnings summariesTechnical Analysis
Ownership Overview
13.67% Insiders
13.07% Mutual Funds
23.62% Other Institutional Investors
41.13% Public Companies and
Individual Investors